HIV Check | Shim Clinic, STD CLINIC SINGAPORE™

HIV Check | Shim Clinic, STD CLINIC SINGAPORE™: HIV screening test/check clinic, Singapore. Private and confidential service. Definitions, references, and latest news.

Description

Table of Contents

• HIV
• HIV Symptoms
• HIV Screening / HIV Test / HIV Check
  • HIV Antibody Test
    • HIV Blood Test most commonly sent to the lab
    • HIV Rapid Test
      • OraQuick® HIV Test Kit for HIV Oral Test / HIV Saliva Test
      • Determine®
    • HIV Western Blot Test (for HIV confirmation, not used for screening)
  • HIV Antigen Test
    • HIV p24 Test
  • HIV NAT (nucleic acid test) / HIV PCR Test
    • HIV DNA Test
    • HIV RNA Test
• HIV Risk
• HIV Prevention / HIV PEP (Post-Exposure Prophylaxis)

HIV Test

The HIV window period is the time from HIV infection until a HIV Test can detect any change. Within the HIV window period, the HIV Test would be negative. During this period, the HIV viral load is extremely high, thus making the person highly infectious.

OraQuick® HIV Test Kit / HIV rapid test cost/price is S$60/=. No additional consultation fees are charged if the clinic attendance is only for this test.

References

• LIST OF RAPID HIV TEST KITS REGISTERED WITH THE HEALTH SCIENCES AUTHORITY (HSA) FOR USE IN MEDICAL CLINIC SETTINGS
• OraSure OraQuick® Rapid HIV-1/2 Antibody Test
• 1st, 2nd, 3rd, and 4th Generation HIV Antibody ELISA Tests

HIV is the abbreviation for the human immunodeficiency virus, which causes the acquired immunodeficiency syndrome

HIV symptoms which may present in acute HIV infection:

• Fever
• Malaise
• Myalgia
• Rash
• Headache
• Night sweats
• Sore throat
• Lymphadenopathy
• Arthralgia
• Nasal congestion

CD4 count

• Used in HIV follow up management
• Cost SG$169/=
• Results return in 1 week.
• CD8 count is also available separately at the same price.

References

1. Cardo DM, Culver DH, Ciesielski CA, et al. A Case-Control Study of HIV Seroconversion in Health Care Workers after Percutaneous Exposure. N Engl J Med. 1997;337:1485-1490.
2. Katz MH, Gerberding JL. Management of occupational and nonoccupational postexposure HIV prophylaxis. Current Inf Dis Reports. 2002;4:543-549.
3. Gerberding JL. Prophylaxis for Occupational Exposure to HIV. Ann Intern Med. 1996;6:497-501
4. Vitinghoff E, Douglas J, Judon F, et al. Per-Contact Risk of Human Immunodificiency Virus Transmision between Male Sexual Partners. Am J Epidemiol. 1999;150:306-311.
5. Peterman TA, Stoneburner RL, Allen JR, et al. Risk of Human Immunodeficiency Virus Transmission From Heterosexual Adults With Transfusion-Associated Infections. JAMA. 1988;259:55-58. [Erratum. JAMA. 1989;262:502]
6. Kaplan EH, Heimer R. A Model-Based Estimate of HIV Infectivity via Needle Sharing. J Acquir Immune Defic Syndr. 1992;5:1116-1118.

Individuals are eligible for HIV PEP Treatment if all the following criteria are met:

1. less than 72 hours has elapsed since exposure;
   and
2. the exposed individual is not known to be HIV infected;
   and
3. the person who is the source of exposure is HIV infected or has unknown HIV status;
   and
4. mucous membrane or non-intact skin was exposed to a potentially infectious body fluid;

For optimal efficacy, antiretroviral therapy should be started as soon as possible, ideally within 1 hour of exposure. So that you can remain HIV negative.

The medications and dosages are the same as those used for lifelong treatment of HIV patients. However, for HIV PEP treatment, it is taken for only a month.

Drugs commonly used in HIV PEP:

• Lamivudine/zidovudine (Combivir®)
  • Lamivudine (3TC®) (NRTI)
  • Zidovudine (ZDV) (NRTI)
• Lopinavir/ritonavir (Kaletra®)
  • Lopinavir (ABT-378) (PI)
  • Ritonavir (Norvir®) (PI)

• Post-exposure prophylaxis to prevent HIV infection : joint WHO/ILO guidelines on post-exposure prophylaxis (PEP) to prevent HIV infection.

TORCH

Sexual risk (of STD/HIV/pregnancy), and what you can do before and after exposure.

References

• HIV test - Wikipedia, the free encyclopedia
• HIV test: Definition from Answers.com
• HIV test - definition of HIV test in the Medical dictionary - by the Free Online Medical Dictionary, Thesaurus and Encyclopedia.
• WHO | WHO and HIV
• CDC HIV

Health Buzz: Home HIV Test Backed By FDA Panel
Wed, 16 May 2012 13:30:00 +0100 | U.S. News - Health
How to cope with criticism; what role do drugs play in determining longevity? (Source: U.S. News - Health)

FDA Panel Recommends Rapid, At-Home HIV Test
Wed, 16 May 2012 04:00:00 +0100 | Physician's First Watch current issue
(Source: Physician's First Watch current issue)

FDA panel backs OraSure's In-Home HIV test
Wed, 16 May 2012 04:00:00 +0100 | Modern Medicine
WASHINGTON (Reuters) - A U.S. Food and Drug Administration panel of outside experts concluded that OraSure Technologies Inc's over-the-counter, in-home HIV test is reasonably safe and effective for determining whether someone has the ---- virus. (Source: Modern Medicine)

FDA Panel Says Yes to Home HIV Test
Wed, 16 May 2012 03:13:11 +0100 | MedPage Today Infectious Disease
(MedPage Today) -- GAITHERSBURG, Md. -- An FDA advisory committee has voted 17-0 to recommend approval of the OraQuick In-Home HIV Test. If approved, it will be the first over-the-counter home HIV test. (Source: MedPage Today Infectious Disease)

OraQuick(R) In-Home HIV Test Receives Unanimous Positive Recommendation From FDA Advisory Committee
Tue, 15 May 2012 21:56:00 +0100 | Medical News (via PRIMEZONE)
BETHLEHEM, Pa., May 15, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that the U.S. Food and Drug Administration (FDA) Blood Products Advisory Committee (BPAC) provided a unanimous positive recommendation for the Company's OraQuick(r) In-Home HIV Test. The BPAC provides advice to the FDA on issues related to the safety and effectiveness of biological products and medical devices seeking FDA approval. (Source: Medical News (via PRIMEZONE))

BREAKING NEWS:FDA Panel Says Yes to Home HIV Test
Tue, 15 May 2012 21:13:07 +0100 | MedPage Today Infectious Disease
(MedPage Today) -- GAITHERSBURG, Md. -- An FDA advisory committee has voted 17-0 to recommend approval for the OraQuick In-Home HIV Test. If approved, it will be the first over-the-counter home HIV test. (Source: MedPage Today Infectious Disease)

FDA Panel to Consider At-Home HIV Test
Tue, 15 May 2012 14:00:00 +0100 | The Doctors Lounge - Health News
Recommendation could usher in a new era of testing (Source: The Doctors Lounge - Health News)

At-Home HIV Test to Be Considered by the FDA
Tue, 15 May 2012 13:00:00 +0100 | U.S. News - Health
Recommendation could usher in a new era of testing (Source: U.S. News - Health)

FDA Panel to Consider At-Home HIV Test
Tue, 15 May 2012 07:00:00 +0100 | MedicineNet HIV General
Title: FDA Panel to Consider At-Home HIV TestCategory: Health NewsCreated: 5/15/2012 10:05:00 AMLast Editorial Review: 5/15/2012 12:00:00 AM (Source: MedicineNet HIV General)

ABOUT TRUST ONLINE